Improved life sciences business systems and methods are disclosed. One or
more genomes are scanned for single nucleotide polymorphisms. The
polymorphisms are used in association studies for pharmaceutical and
diagnostic developments. In certain embodiments, an association study
comprises both genotyping of these polymorphisms and resequencing of
genomic regions that contain polymorphisms associated with a phenotypic
state of interest.